[Use of inotropic agents in the treatment of cardiac insufficiency].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D002908:Chronic Disease; D003327:Coronary Disease / Q000150:complications; D004071:Digitalis Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007476:Ionophores / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D002395:Catecholamines; D004071:Digitalis Glycosides; D007476:Ionophores; D010726:Phosphodiesterase Inhibitors
Empleo de inotrópicos en el tratamiento de la insuficiencia cardiaca.